Myocardial ischaemia during pharmacological stress echocardiography is a strong prognostic predictor in patients with a left bundle branch block (LBBB). However, the additive value of Doppler-derived coronary flow reserve (CFR) during pharmacological stress testing remains to be investigated in this subset of patients.
Introduction
The assessment of coronary artery disease (CAD) in patients with a left bundle branch block (LBBB) remains a challenge in current cardiology practice, as exercise electrocardiogram is uninterpretable, 1 and reversible perfusion defects in the left anterior descending (LAD) coronary artery territory have low diagnostic specificity. 2, 3 In spite of the difficulty posed by abnormal wall motion, stress echocardiography is the best diagnostic option in these patients. 4 It is more specific than perfusion imaging, 4 -6 and its sensitivity is good, albeit reduced in the LAD territory in the presence of a dyskinetic septum in resting conditions. 7 Moreover, myocardial ischaemia induced by pharmacological 8 or exercise 9 stress echocardiography has a strong and independent power for the correlation with future death or myocardial infarction (MI) in LBBB patients. In recent years, the combination of conventional wall motion analysis and two-dimensional-echo and coronary flow reserve (CFR) with pulsed Doppler flowmetry of mid-distal LAD during vasodilator stress echocardiography has entered the echo lab as an effective modality for both diagnostic and prognostic purposes, 10 being virtually unaffected by concomitant antiischaemic medication. 11, 12 It has been demonstrated that coronary flow reserve adds prognostic information to stress echocardiography results in several clinical settings, such as patients with known or suspected CAD, 13 diabetes mellitus, 14 normal or nearnormal coronary arteries, 15 and arterial hypertension. 12 However, data on LBBB are still lacking. The aim of the study was to investigate the prognostic implication of CFR on LAD in an unselected cohort of patients with LBBB evaluated in a large scale, multi-centre, observational, and prospective study design.
Methods Patients
The study group consisted of 324 patients [187 men; mean (+SD) age 68 + 10 years] with complete LBBB on the resting electrocardiogram who were evaluated at four Italian Cardiology Institutions (Lucca, Mestre, Cesena, Pisa) from August 2003 to August 2011 for enrollment in a study focused on assessing the prognostic value of CFR in the setting of known or suspected CAD. It was an observational, not randomized, and prospective study, and patients were entered the databank at the time of initial assessment. All the patients underwent stress echocardiography with wall motion and CFR assessment of LAD by transthoracic Doppler ultrasound. The criteria for a LBBB were a QRS complex of ≥120 ms; upright notched or slurred R-wave in leads I, aVL, and V 6 ; rS or a QS complex in lead V 1 ; absence of septal Q-wave in V 5 and V 6 ; displacement of the ST-segment and T-wave in the opposite direction from the QRS complex. The exclusion criteria were significant valvular or congenital heart disease, prognostically relevant non-cardiac diseases (cancer, end-stage renal disease, or severe obstructive pulmonary disease), and inadequate acoustic window precluding satisfactory imaging of left ventricle (for 2D echo) or of LAD flow Doppler (for CFR assessment). Follow-up information was available for all the patients. Indications for stress echocardiography were suspected CAD in 250 (77%) individuals and risk stratification for known CAD (i.e. history of MI, coronary revascularization, and/or angiographic evidence of ≥50% diameter coronary stenosis) in the remaining 74 (23%). According to individual needs and physician's choices, 168 (52%) patients were evaluated after anti-anginal drugs had been discontinued, and 156 (48%) patients were evaluated during anti-anginal treatment ( Table 1) . Phylline-containing drugs or beverages were discontinued at least 24 h before testing. All the patients gave their written informed consent when they underwent stress echocardiography. When the patients signed the written informed consent, they also authorized physicians to use their clinical data. Stress echo data were collected and analysed by stress echocardiographers not involved in patient care.
Stress echocardiography
Transthoracic stress echocardiographic studies were performed with commercially available ultrasound machines (Sonos 7500 or iE 33, Philips Ultrasound, Andover, MA, USA; Vivid System 7, GE/Vingmed, Milwaukee, Wis; Sequoia C256 Acuson Siemens Mountain View, CA, USA) equipped with a multifrequency phased-array sector scan probe (S3-S8 or V3 -V7) and with second harmonic technology. Two-dimensional echocardiography and 12-lead electrocardiographic monitoring were performed in combination with high-dose dipyridamole (up to 0.84 mg over 6 min). 10 Echocardiographic images were semiquantitatively assessed using a 17 segments, 4-point scale model of the left ventricle. 16 For septal contraction, impaired wall thickening was the only criterion for regional dyssynergy 7, 8 ; typical systolic asynchronous motion 17, 18 was not considered abnormal. 7, 8 A wall motion score index was calculated by dividing the sum of individual segment scores by the number of interpretable segments. Ischaemia was defined as stress-induced new and/or worsening of pre-existing wall motion abnormality. A test was considered positive for ischaemia only on the basis of wall motion analysis. Rest wall motion abnormality was akinetic or dyskinetic myocardium with no thickening during stress. The left ventricular ejection fraction was assessed in the standard four-chamber view using the area-length method. 19 Coronary flow reserve was assessed during the standard stress echo examination by an intermittent imaging of both wall motion and LAD flow. 10 The coronary flow in the mid-distal portion of LAD was searched in the low parasternal long-axis section under the guidance of colour Doppler flow mapping. 10 Contrast was not used for the assessment of CFR in any of the study patients. All studies were digitally stored to simplify off-line reviewing and measurements. Coronary flow parameters were analysed off-line using the built-in calculation package of the ultrasound unit. Flow velocities were measured ≥2 times for each study, namely at baseline and at peak stress (before aminophylline injection). At each time point, three optimal profiles of peak diastolic Doppler flow velocities were measured, and the results were averaged. Coronary flow reserve was defined as the ratio between hyperaemic peak and basal peak diastolic coronary flow velocities. A CFR value of ≤2.0 was considered abnormal. 14 In Figure 1 are depicted examples of normal and impaired CFR assessed by transthoracic Doppler of LAD. All the investigators of the contributing centres passed quality control criteria for regional wall motion and Doppler interpretation prior to entering the study as previously described. 20 The feasibility of CFR assessment on LAD is 94%. 14 The previously assessed intraand inter-observer variability for measurements of Doppler recordings and regional wall motion analysis assessment were ,10%.
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Quality control of stress echocardiographic readings
Quality control of the diagnostic performance in the different centres was of critical importance to acquire meaningful information into the data bank. In the enrolled centres, quality control was performed on the basis of two criteria, each one having to be met to fulfill the quality control requirements. 22, 23 The first criterion was tested on a series of 20 digitally stored stress echo studies prepared in the coordinating centre (Institute of Clinical Physiology in Pisa). In all these 20 studies, the reading of two experienced independent observers was concordant as to the presence and the site of dyssynergy, and the stress results were in full agreement with the presence and the site of coronary stenoses during coronary angiography. The unanimous Coronary flow reserve in left bundle branch block reading of the two observers was arbitrarily assumed to be the 'gold standard' against which to evaluate the reading of each participating centre. The reader from each centre interpreted the videotape in a blinded fashion, with no access either to clinical and angiographic data or to the interpretation given by other observers. It was assumed a priori that the minimum threshold of concordance to pass this part of the quality control had to be 90%. The second criterion consisted in randomly sampling 20 consecutive studies from each contributing centre. These 20 studies were examined in a blinded fashion by an experienced cardiologist-echocardiographist of the coordinating centre-whose reading was arbitrarily assumed to be the 'gold standard'. It was assumed a priori that the minimum threshold of concordance to pass the quality control had to be 80%. The lower concordance cut-off in comparison with the first type of reading is due to the fact that this second set of cases was not selected on the basis of the superior quality but randomly sampled from each centre in a consecutive fashion. All the enrolled centres met the minimum requirements of quality control.
Coronary angiography
Coronary angiography was performed in a subset of patients and indicated on the basis of clinical findings and stress echo result which was available to the referral cardiologist. Multiple views were adopted according to the standard Judkins or Sones technique. At least five views (including two orthogonal views) were acquired for the left and at least two orthogonal views for the right coronary arteries. Additional appropriate projections were obtained in case of superimposition of side branches or foreshortening of the segment of interest. Obstructive CAD was defined by a quantitatively assessed coronary stenosis of ≥50%. visiting the patients at regular intervals in the out-patient clinic. Clinical events were defined as death and non-fatal acute MI. To avoid misclassification of the cause of death, 24 the overall mortality was considered. Coronary revascularization (surgery or angioplasty) was also registered; however, it was not identified as a clinical event. Follow-up data were analysed for the correlation with mortality and death or MI. When more than one of these events occurred, the patient was censored at the time of the first occurring event.
Follow-up data
Statistical analysis
Continuous variables are expressed as mean + SD. Differences between groups were compared using two-sided Student's t and the chi-square test, as appropriate. For variables not normally distributed, the two-sample Wilcoxon rank sum (Mann -Whitney) was used for comparison and median and relative inter-quartile range were reported. Survival rates were estimated with Kaplan-Meier curves and compared by the log-rank test. Patients undergoing coronary revascularization were censored at the time of the procedure. Annual event rates were obtained from Kaplan-Meier estimates to take censoring of the data into account. A multivariate analysis was done using the Cox proportional hazard regression model. The proportionality for each predictors was tested as indicated by Kleinbaum and Klein 25 A significance of 0.05 was required for a variable to be included into the multivariate model, while 0.1 was the cut-off value for exclusion. Hazard ratios (HRs) with the corresponding 95% confidence interval (CI) were estimated. The following covariates were analysed: age, sex, QRS width, family history of CAD, diabetes mellitus, arterial hypertension, hypercholesterolaemia, smoking habit, prior MI, prior coronary artery by-pass grafting, prior percutaneous revascularization, ongoing anti-ischaemic therapy, resting wall motion abnormality, resting wall motion score index, ischaemia at stress echo, wall motion score index at peak stress, test positivity, resting velocity on LAD, and CFR on LAD. Statistical significance was set at P , 0.05. Moreover, clinical findings, resting wall motion score index, ongoing anti-ischaemic therapy, ischaemia at stress echo, and reduced CFR on LAD were sequentially included into the model. The global X 2 value of the model was calculated from the log likelihood ratio; a significant increase after the addition of further variables indicated incremental prognostic value. Statistical Package for the Social Sciences (IBM, SPSS Statistics, version 20) was used for analysis.
Results
Stress echocardiographic findings
No major complications occurred during stress echocardiography. Ischaemia was documented in 52 (16%) patients. Of 272 individuals Coronary flow reserve is calculated as the ratio between peak diastolic coronary flow velocity at hyperaemia and its value in resting condition. The normal finding is characterized by CFR .2 associated with angiographically normal coronary arteries (upper row). In the presence of significant stenosis of the left anterior descending artery, CFR is ≤2 (second row). Coronary flow reserve can be ≤2 also in the presence of normal coronary anatomy, indicating underlying microvascular disease (third row).
Coronary flow reserve in left bundle branch block with stress echo negative for ischaemia, 119 (44%) had been investigated under anti-ischaemic medication. The mean CFR on LAD was 2.18 + 0.60. There were 139 (43%) patients with CFR ≤2 and 185 (57%) with CFR .2. A CFR of ≤2 was assessed in 45 (87%) subjects with ischaemia and in 94 (35%) without ischaemia at stress echo (60 tested on anti-ischaemic therapy, and 34 off therapy) ( Table 1) .
Patients with CFR ≤2 were more often men, had a higher incidence of diabetes mellitus and prior MI and worse resting left ventricular ejection fraction, and were evaluated more often under therapy than patients with CFR .2 ( Table 1) . The average QRS width in the study population was 141 + 16 ms, and no difference (P ¼ 0.16) between subjects with CFR ≤2 and CFR .2 was observed ( Table 1) .
Two-hundred and four (63%) patients underwent clinically driven coronary angiography within 1 month of stress echocardiography, showing obstructive CAD in 81 (40%) patients, of whom 62 had LAD stenosis, and normal or near-normal coronary arteries in 123 (60%) patients.
Survival analysis
During a median follow-up of 15 months (first to third quartile: 8 -34 months), 51 (16%) events (37 deaths and 14 MI) were registered.
According to the physician's judgement, 52 (16%) patients underwent coronary revascularization with surgery (n ¼ 17) or angioplasty (n ¼ 35) after a median of 150 days (first to third quartile: 70-228 days) from the index stress echo: 24 with ischaemia and 28 without ischaemia (46 vs. 10%; P , 0.0001). There were 38 revascularizations among patients with CFR ≤2 and 14 among those with CFR .2 (27 vs. 8%; P , 0.0001).
The annual mortality and event rate associated with a stress echo positive for ischaemia were 20.5 and 38.7%, respectively. The corresponding figures for a non-ischaemic test were 5.0 and 6.1%. The annual mortality and event rate associated with a CFR of ≤2 were 15.5 and 20.9%, respectively. The corresponding figures for a CFR .2 were 1.9 and 2.9%.
In Table 2 the results of Cox analysis are listed. Multivariable indicators of mortality were in decreasing order, age (P , 0.0001), resting wall motion score index (P , 0.0001), smoking habit (P , 0.0001), and CFR on LAD ≤2 (P ¼ 0.001). Independent predictors of death or MI resulted CFR on LAD ≤2 (P , 0.0001), age (P ¼ 0.001), smoking habit (P ¼ 0.01), ischaemia at stress echo (P ¼ 0.02), and resting wall motion score index (P ¼ 0.02). QRS median time duration failed to be correlated with mortality and death or MI ( Table 2) .
Four-year mortality rate and 4-year hard event rate were markedly higher in patients with CFR ≤2 than in those with CFR .2 (49 vs. 6% and 56 vs. 8%, respectively; P , 0.0001 for both) (Figure 2) , as well as in patients with a positive test for myocardial ischaemia based on conventional wall motion analysis than in those with a negative test (71 vs. 17% and 80 vs. 20%, respectively; P , 0.0001 for both) (Figure 3) . The rates of death or MI at the 4-year follow-up were higher in patients with CFR ≤2 than in those with CFR .2 also when the subset with normal coronary arteries and a negative test for wall motion criteria was separately analysed (53 vs. 7%, P , 0.0001) (Figure 4) . A CFR of ≤2 conferred effective prognostic information in different clinical subsets, being associated with a significantly greater incidence of hard event per year independently of age, sex, left ventricular ejection fraction, history of CAD, diabetes mellitus, and arterial hypertension ( Figure 5 ). In addition, CFR ,2 showed an increased (P , 0.0001) yearly mortality and MI rate in patients with a negative test result obtained on medical therapy, whereas no statistically significant difference was observed in the negative tests conducted off medical therapy ( Figure 6) . No significant interaction between therapy and CFR was observed (P . 0.48 for mortality and P . 0.25 for death or MI).
The global X 2 clinical model for mortality correlation mortality was 35.5 (P , 0.0001); sequential inclusion of resting wall motion score index, ongoing anti-ischaemic therapy, ischaemia at stress echo, and CFR ≤2 increased it by 86% (65.9; P , 0.0001), 14% (73.0; P , 0.0001), 7% (77.9; P , 0.0001), and 17% (91.4; P , 0.0001), respectively. Considering death or MI as a clinical endpoint, the clinical model provided a global X 2 of 33.2 (P , 0.0001). After the addition of resting wall motion score index, ongoing anti-ischaemic therapy, ischaemia at stress echo, and CFR ≤2, it increased by 52% (50.5; P , 0.0001), 17% (59.0; P , 0.0001), 22% (72.0; P , 0.0001), and 20% (86.7; P , 0.0001), respectively. Considering the group of 204 patients with available angiographic data, the global X 2 clinical model for death or MI correlation was 18.3 (P ¼ 0.07); sequential inclusion of resting wall motion score index, ongoing anti-ischaemic therapy, ischaemia at stress echo, CFR on LAD ≤2, and obstructive CAD at coronary angiography increased it by 72% (31.4; P ¼ 0.003), 35% (42.5; P , 0.0001), 15% (48.8; P , 0.0001), 37% (66.7; P , 0.0001), and 3% (69.0; P , 0.0001), respectively.
Discussion
LBBB is a frequent, aetiologically heterogeneous, and clinically and diagnostically challenging entity. From 4 to 7% of patients referred for stress echocardiography exhibit LBBB. 9, 26 Although this conduction defect is a recognized predictor of unfavourable cardiac outcome per se, 2 -4 the prognosis is primarily determined by underlying cardiac pathology. 27, 28 As CAD is a leading cause of LBBB, the search for optimal non-invasive modality to risk-stratify LBBB patients is of relevance on clinical grounds. In a previous study of unselected patients with LBBB, the extent of ischaemia during pharmacological stress echocardiography was independently associated with cardiac death, while test positivity alone predicted the combined endpoint of cardiac death or MI. 8 Moreover, the result of stress echo added significant value to the prediction of clinical and resting echocardiographic evaluation in subjects without previous MI, but not in those with previous infarction. 8 In another experience, the extent of ischaemia during exercise stress echocardiography provided significant prognostic information for the prediction of all-cause mortality and major cardiac events in a cohort of LBBB patients with proven or suspected CAD. 9 Finally, in subjects with symptoms suggestive of CAD but no evidence of cardiac disease, pharmacological stress echocardiography yielded high and comparable negative predictive value in the group with an LBBB and in the group with no intraventricular conduction defect.
29 Abbreviations as in Table 1 .
The results of the current study confirm the capability of stress-induced ischaemia to identify LBBB patients at an increased risk of death or MI and, most importantly, demonstrate the superior prognostic power of CFR on LAD with respect to conventional wall motion analysis. In fact, impaired CFR was a strong and independent indicator of overall mortality and death or MI, and added prognostic value over clinical, resting echo, and stress echocardiography parameters. Abnormal CFR was associated with a markedly increased annual risk of death or MI in both sexes, and in different clinical groups defined by age, resting left ventricular function, history of CAD, diabetes mellitus, and arterial hypertension. Of note, a CFR ≤ of 2 allowed effective risk assessment also in patients with no inducible ischaemia, particularly in the case they had been tested under medical therapy, predicting nearly eight-fold higher annual mortality and 10-fold higher annual hard event rate compared with CFR .2. These results on LBBB patients expand those obtained in previous studies, demonstrating an additive prognostic value of CFR in different clinical populations, ranging from patients with known or suspected CAD 13 to those with diabetes mellitus, 14 normal or near-normal coronary arteries, 15 and arterial hypertension. 12 Inducible ischaemia was detected in 16% of the population under investigation, whereas in previous studies the rate of test positivity was 28 and 29% on a general LBBB patient population. 8, 9 The different proportion of exams conducted under anti-ischaemic therapy may have accounted for this, as 38% of our patients vs. only 4 to 5% of those in previous studies were tested under b-blocking agents. Therapy lowers the diagnostic accuracy 30, 31 and the prognostic capability 32 of stress echocardiography, while it exerts a negligible effect on the diagnostic 12 and prognostic 11 value of CFR. Coronary flow reserve is, however, more sensitive than wall motion analysis in detecting significant LAD stenosis, 33 and in LBBB patients wall motion interpretation remains challenging because of the paradoxical movement of the septum, 7 whereas CFR is quantitatively obtained and not influenced by movement. Again, this may have influenced the present results. In addition, CFR allows investigation of not only organic Figure 3 The mortality rate and death or MI rate for the study population separated on the basis of the presence (ischaemia) or absence (no ischaemia) of ischaemia at stress echocardiography. The number of patients per year is shown.
CAD, but also microvascular impairment. In fact, abnormal CFR was shown to independently correlate with conventional Framingham risk factors, 34 and to confer markedly increased risk of future events both in unselected series of chest pain patients 15 and in hypertensive patients 12 with angiographically normal coronary arteries or non-significant CAD.
Clinical implications
The clinical implications of the present study are relevant. Even though LBBB is an ominous prognostic parameter per se, vasodilator stress echocardiography has the ability to further risk-stratify these patients, identifying those at a higher risk of death. Stress echo results cannot be interpreted with a dichotomic approach, positive/negative, but different strata of risk are given relative to the extent and severity of inducible ischaemia, expressed by the value of the wall motion score index and by the reduction beyond a certain level of CFR. Coronary angiography should be reserved for those patients with a low pharmacological load/extensive myocardial ischaemia as expressed by the wall motion score index subtending a potentially severe CAD. The indication to coronary angiography on the basis only of CFR has relevant limitations since severe microvascular impairment cannot be distinguished by ischaemia induced by stenosis severity. However, microvascular disease is not prognostically neutral and represents a clinical scenario to be medically treated. More studies are needed to investigate the changes of therapeutic interventions in these patients. Moreover, stress echocardiography has clear advantages on top of diagnostic and prognostic yield compared with other noninvasive imaging techniques as regards cost, availability, and lack of ionizing radiations. In a cost-containment environment that is envisioning the need to reduce health-care costs and useless and potentially harmful exams, stress echocardiography may and should play a pivotal role. It is hard to believe that other imaging Figure 4 The death or MI rate for the study population with a negative test for myocardial ischaemia and normal coronary arteries at angiography separated on the basis of the coronary flow reserve (CFR) on the left anterior descending artery ≤2 or .2. The number of patients per year is shown. Figure 5 The annual death or MI rate in different clinical group defined by sex, age, resting left ventricular ejection fraction, history of CAD, diabetes mellitus, and arterial hypertension and separated on the basis of the coronary flow reserve on the left anterior descending artery ≤2 or .2.
Coronary flow reserve in left bundle branch block modalities may provide the same wealth of information at such a low patient and environmental cost.
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Limitations of the study
In this study, there was no central reading. Stress echocardiography and CFR measurement were interpreted in the peripheral centres and entered directly in the data bank. This system allowed substantial sparing of human and technological resources, but it was also the logical pre-requisite for a large-scale study, designed to represent the realistic performance of the test rather than the results of a single lab-or even a single person-working in a highly dedicated echo laboratory. Because the assessment of the echocardiograms was qualitative and subjective, variability in reading the echocardiograms might have modulated the results of individual centres. 37 However, all our readers in individual centres had a long-lasting experience in echocardiography and passed the quality control in stress echo reading as previously described. 20 Test results were made available to the referring physician and this may have influenced the management/treatment of the patients, especially those with a positive test for myocardial ischaemia. However, physicians performing stress echocardiography were not responsible for patient management. The CFR was sampled only on LAD. There is no doubt that the three coronaries approach would be more fruitful, but at present it remains too technically challenging for a large-scale assessment. In the present study, the follow-up was censored at the time of revascularization, and no data are available on the effect of treatments (surgery or angioplasty).
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